ambossIconambossIcon

Angioedema

Last updated: November 20, 2024

Summarytoggle arrow icon

Angioedema is a self-limited, localized swelling of the dermis, subcutaneous tissues, and/or submucosal tissues caused by fluid leakage into the interstitial tissue. It is mediated by vasoactive substances and can be classified as histamine-mediated (often secondary to allergic reactions and NSAIDs), bradykinin-mediated (due to ACE inhibitor use or enzyme deficiencies), or unknown (idiopathic). Patients usually present with swelling of the eyelids, lips, and tongue. However, life-threatening laryngeal edema may occur, which requires immediate airway protection. Treatment generally consists of aggressive supportive care and avoidance of triggers, if applicable. In acute cases, histamine-mediated angioedema is treated with systemic glucocorticoids, antihistamines, and, if necessary, epinephrine for anaphylaxis. Bradykinin-mediated angioedema is treated with C1 inhibitor (C1-INH) concentrate, bradykinin-B2-receptor antagonists, or kallikrein inhibitors.

Urticaria is defined as the presence of hives with or without angioedema. See “Urticaria” for additional information.

Icon of a lock

Register or log in , in order to read the full article.

Overviewtoggle arrow icon

Differentiation between histamine-mediated angioedema and bradykinin-mediated angioedema [1][2]
Histamine-mediated angioedema Bradykinin-mediated angioedema
Hereditary angioedema types I–III Acquired angioedema
Onset
  • Minutes
  • Hours
Duration
  • 12–24 hours
  • 24–48 hours
Usual age
  • Any
  • < 20 years
Family history
  • Possible
  • Common
  • Uncommon
Cause/trigger [3][4]

Prodrome

  • No
  • Common
  • Uncommon

Associated symptoms

Laryngeal edema
  • Possible
  • Common
Extremity or truncal edema
Gastrointestinal symptoms
Bronchospasm
  • Common
  • Uncommon
Hives
Hypotension
Response to standard anaphylaxis treatment
  • Good
  • Poor
Icon of a lock

Register or log in , in order to read the full article.

Classificationtoggle arrow icon

Histamine-mediated angioedema (mast cell-mediated angioedema) [1][2]

Bradykinin-mediated angioedema [2][6]

Angioedema of unknown cause [2][5]

Icon of a lock

Register or log in , in order to read the full article.

Clinical featurestoggle arrow icon

Common symptoms

Histamine-mediated angioedema

Bradykinin-mediated angioedema

References:[7]

Icon of a lock

Register or log in , in order to read the full article.

Diagnosistoggle arrow icon

Laboratory findings in bradykinin-mediated angioedema [6]
Hereditary angioedema Acquired angioedema
Type I Type II Type III ACE-inhibitor induced C1-INH deficiency
C1-INH level Normal Normal Normal
C1-INH function Normal Normal
C4 level ↓ During acute attacks ↓ During acute attacks Normal Normal
C1q level Normal Normal Normal Normal
Icon of a lock

Register or log in , in order to read the full article.

Differential diagnosestoggle arrow icon

The differential diagnoses listed here are not exhaustive.

Icon of a lock

Register or log in , in order to read the full article.

Managementtoggle arrow icon

Approach

Emergency management [2][5][9][10]

If airway compromise is suspected (stridor, wheezing, diminished air movement) or the patient is in shock, administer IM epinephrine immediately, start oxygen and IV fluids, and consider intubation to protect the airway. Once acute therapy has been initiated, the type and cause of angioedema should be determined.

Intubation is very risky in patients with angioedema and should only be performed by an expert. If there is no time for help, then preparation for the procedure must also include rescue devices and surgical airway equipment.

Case-based specific treatment [2][5]

Treatment of histamine-mediated angioedema and treatment of idiopathic angioedema

Treatment of bradykinin-mediated angioedema and treatment of hereditary angioedema [8][10]

Epinephrine, glucocorticoids, and antihistamines are usually not effective in acute hereditary angioedema attacks! If these have been given empirically (e.g., for suspected anaphylaxis with airway compromise) and there is a poor response, then targeted therapy for bradykinin-mediated angioedema should be considered as the next step.

Icon of a lock

Register or log in , in order to read the full article.

Acute management checklisttoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Preventiontoggle arrow icon

General [2]

  • Trigger avoidance (e.g., allergens, offending medications, environmental factors)
  • Counseling on symptom recognition and instructions for when to return to the hospital
  • Prespecified treatment action plans

Specific

Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer